{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:36:50Z","timestamp":1792093010829,"version":"4.4.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10096-026-05484-7","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:50:35Z","timestamp":1774291835000},"page":"1867-1890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antibiotic resistance mechanisms and global resistance patterns of Pseudomonas aeruginosa in microbial keratitis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-9364","authenticated-orcid":false,"given":"Tanzina","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7858-6044","authenticated-orcid":false,"given":"Shiful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8067-0851","authenticated-orcid":false,"given":"Abrar Maswood","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaniz","family":"Fatema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-5443","authenticated-orcid":false,"given":"Fiona","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-7563","authenticated-orcid":false,"given":"Mark","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"5484_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jtos.2021.08.007","volume":"28","author":"F Stapleton","year":"2023","unstructured":"Stapleton F (2023) The epidemiology of infectious keratitis. Ocul Surf 28:351\u2013363","journal-title":"Ocul Surf"},{"issue":"9174","key":"5484_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(98)09385-4","volume":"354","author":"KH Cheng","year":"1999","unstructured":"Cheng KH, Leung SL, Hoekman HW, Beekhuis WH, Mulder PG, Geerards AJ, Kijlstra A (1999) Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 354(9174):181\u2013185","journal-title":"Lancet"},{"issue":"3","key":"5484_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/ICO.0b013e31815c5a3f","volume":"27","author":"A Pinna","year":"2008","unstructured":"Pinna A, Usai D, Sechi LA, Molicotti P, Zanetti S, Carta A (2008) Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers. Cornea 27(3):320\u2013326","journal-title":"Cornea"},{"issue":"8","key":"5484_CR4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/pharmaceutics16081074","volume":"16","author":"L Badger-Emeka","year":"2024","unstructured":"Badger-Emeka L, Emeka P, Thirugnanasambantham K, Alatawi AS (2024) The Role of Pseudomonas aeruginosa in the Pathogenesis of Corneal Ulcer, Its Associated Virulence Factors, and Suggested Novel Treatment Approaches. Pharmaceutics 16(8):1074","journal-title":"Pharmaceutics"},{"issue":"2","key":"5484_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/iai.65.2.579-586.1997","volume":"65","author":"SM Fleiszig","year":"1997","unstructured":"Fleiszig SM, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE, Kanada D, Sawa T, Yen TS, Frank DW (1997) Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65(2):579\u2013586","journal-title":"Infect Immun"},{"issue":"2","key":"5484_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jamaophthalmol.2013.778","volume":"131","author":"DS Borkar","year":"2013","unstructured":"Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD (2013) Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol 131(2):147\u2013153","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"5484_CR7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/pharmaceutics17091184","volume":"17","author":"M Josef","year":"2025","unstructured":"Josef M, Abdellatif MM, Abdelmonem R, El-Nabarawi MA, Teaima M, Bedair HM, Attia A (2025) Invasomes and Nanostructured Lipid Carriers for Targeted Delivery of Ceftazidime Combined with N-Acetylcysteine: A Novel Approach to Treat Pseudomonas aeruginosa-Induced Keratitis. Pharmaceutics 17(9):1184","journal-title":"Pharmaceutics"},{"key":"5484_CR8","doi-asserted-by":"publisher","first-page":"759271","DOI":"10.3389\/fopht.2021.759271","volume":"1","author":"H Hatami","year":"2021","unstructured":"Hatami H, Ghaffari Jolfayi A, Ebrahimi A, Golmohammadi S, Zangiabadian M, Nasiri MJ (2021) Contact Lens Associated Bacterial Keratitis: Common Organisms, Antibiotic Therapy, and Global Resistance Trends: A Systematic Review. Front Ophthalmol (Lausanne) 1:759271","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"7","key":"5484_CR9","first-page":"Cd015350","volume":"7","author":"A Song","year":"2025","unstructured":"Song A, Yang Y, Henein C, Bunce C, Qureshi R, Ting DSJ (2025) Topical antibiotics for treating bacterial keratitis: a network meta-analysis. Cochrane Database Syst Rev 7(7):Cd015350","journal-title":"Cochrane Database Syst Rev"},{"key":"5484_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","volume":"2","author":"K Poole","year":"2011","unstructured":"Poole K (2011) Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2:65","journal-title":"Front Microbiol"},{"issue":"2","key":"5484_CR11","first-page":"255","volume":"3","author":"K Poole","year":"2001","unstructured":"Poole K (2001) Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 3(2):255\u2013264","journal-title":"J Mol Microbiol Biotechnol"},{"key":"5484_CR12","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.drup.2019.07.002","volume":"44","author":"J Botelho","year":"2019","unstructured":"Botelho J, Grosso F, Peixe L (2019) Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution. Drug Resist Updat 44:100640","journal-title":"Drug Resist Updat"},{"issue":"1","key":"5484_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M (2022) Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther 7(1):199","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"5484_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske C, Harbarth S, Hindler J, Kahlmeter G, Olsson-Liljequist B (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"5484_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1462-2920.2002.00321.x","volume":"4","author":"JP Pirnay","year":"2002","unstructured":"Pirnay JP, De Vos D, Cochez C, Bilocq F, Vanderkelen A, Zizi M, Ghysels B, Cornelis P (2002) Pseudomonas aeruginosa displays an epidemic population structure. Environ Microbiol 4(12):898\u2013911","journal-title":"Environ Microbiol"},{"issue":"1","key":"5484_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/cid\/ciae052","volume":"79","author":"MK Grossman","year":"2024","unstructured":"Grossman MK, Rankin DA, Maloney M, Stanton RA, Gable P, Stevens VA, Ewing T, Saunders K, Kogut S, Nazarian E (2024) Extensively drug-resistant Pseudomonas aeruginosa outbreak associated with artificial tears. Clin Infect Dis 79(1):6\u201314","journal-title":"Clin Infect Dis"},{"key":"5484_CR17","doi-asserted-by":"publisher","first-page":"1374466","DOI":"10.3389\/fmicb.2024.1374466","volume":"15","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, Ragab RF, AlHarbi M, Badshah F, Ibanez-Arancibia E, Farag A, Hendawy AO, De Rios-Escalante L, Aboubakr PR, Zakai M, Nageeb SA WM (2024) Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol 15:1374466","journal-title":"Front Microbiol"},{"issue":"31","key":"5484_CR18","doi-asserted-by":"publisher","first-page":"e2107644118","DOI":"10.1073\/pnas.2107644118","volume":"118","author":"J Ude","year":"2021","unstructured":"Ude J, Tripathi V, Buyck JM, Soderholm S, Cunrath O, Fanous J, Claudi B, Egli A, Schleberger C, Hiller S, Bumann D (2021) Outer membrane permeability: Antimicrobials and diverse nutrients bypass porins in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 118(31):e2107644118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5484_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177\u2013192","journal-title":"Biotechnol Adv"},{"issue":"Suppl 1","key":"5484_CR20","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1086\/514909","volume":"27","author":"RE Hancock","year":"1998","unstructured":"Hancock RE (1998) Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 27(Suppl 1):S93\u201399","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5484_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/AAC.01747-15","volume":"60","author":"CJ Balibar","year":"2016","unstructured":"Balibar CJ, Grabowicz M (2016) Mutant Alleles of lptD Increase the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics. Antimicrob Agents Chemother 60(2):845\u2013854","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5484_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/antibiotics11040520","volume":"11","author":"L Huang","year":"2022","unstructured":"Huang L, Wu C, Gao H, Xu C, Dai M, Huang L, Hao H, Wang X, Cheng G (2022) Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview. Antibiot (Basel) 11(4):520","journal-title":"Antibiot (Basel)"},{"issue":"24","key":"5484_CR23","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.3390\/ijms232415779","volume":"23","author":"AB Lorusso","year":"2022","unstructured":"Lorusso AB, Carrara JA, Barroso CDN, Tuon FF, Faoro H (2022) Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa. Int J Mol Sci 23(24):15779","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5484_CR24","doi-asserted-by":"publisher","first-page":"e3001523","DOI":"10.1371\/journal.pbio.3001523","volume":"20","author":"CJ Stubenrauch","year":"2022","unstructured":"Stubenrauch CJ, Bamert RS, Wang J, Lithgow T (2022) A noncanonical chaperone interacts with drug efflux pumps during their assembly into bacterial outer membranes. PLoS Biol 20(1):e3001523","journal-title":"PLoS Biol"},{"issue":"4","key":"5484_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1128\/MMBR.00027-10","volume":"74","author":"VL Kung","year":"2010","unstructured":"Kung VL, Ozer EA, Hauser AR (2010) The accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol Rev 74(4):621\u2013641","journal-title":"Microbiol Mol Biol Rev"},{"issue":"8","key":"5484_CR26","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1073\/pnas.0711982105","volume":"105","author":"K Mathee","year":"2008","unstructured":"Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, Rokas A, Yandava CN, Engels R, Zeng E, Olavarietta R, Doud M, Smith RS, Montgomery P, White JR, Godfrey PA, Kodira C, Birren B, Galagan JE, Lory S (2008) Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 105(8):3100\u20133105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5484_CR27","doi-asserted-by":"crossref","unstructured":"Burmeister AR (2015) Horizontal Gene Transfer. Evol Med Public Health 2015 (1):193\u2013194","DOI":"10.1093\/emph\/eov018"},{"issue":"2","key":"5484_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","volume":"49","author":"K Poole","year":"2005","unstructured":"Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49(2):479\u2013487","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"5484_CR29","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms21228671","volume":"21","author":"MTT Thi","year":"2020","unstructured":"Thi MTT, Wibowo D, Rehm BHA (2020) Pseudomonas aeruginosa Biofilms. Int J Mol Sci 21(22):8671","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5484_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/viru.23724","volume":"4","author":"SM Soto","year":"2013","unstructured":"Soto SM (2013) Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 4(3):223\u2013229","journal-title":"Virulence"},{"issue":"6","key":"5484_CR31","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/microorganisms10061247","volume":"10","author":"KA Simanek","year":"2022","unstructured":"Simanek KA, Paczkowski JE (2022) Resistance Is Not Futile: The Role of Quorum Sensing Plasticity in Pseudomonas aeruginosa Infections and Its Link to Intrinsic Mechanisms of Antibiotic Resistance. Microorganisms 10(6):1247","journal-title":"Microorganisms"},{"issue":"1","key":"5484_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4314\/ahs.v17i1.25","volume":"17","author":"SA El-Mowafy","year":"2017","unstructured":"El-Mowafy SA, Abd El Galil KH, Habib EE, Shaaban MI (2017) Quorum sensing inhibitory activity of sub-inhibitory concentrations of beta-lactams. Afr Health Sci 17(1):199\u2013207","journal-title":"Afr Health Sci"},{"issue":"7054","key":"5484_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/nature03912","volume":"436","author":"LR Hoffman","year":"2005","unstructured":"Hoffman LR, D\u2019Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436(7054):1171\u20131175","journal-title":"Nature"},{"issue":"23","key":"5484_CR34","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/JB.01651-09","volume":"192","author":"LR Mulcahy","year":"2010","unstructured":"Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192(23):6191\u20136199","journal-title":"J Bacteriol"},{"issue":"3","key":"5484_CR35","doi-asserted-by":"publisher","first-page":"101819","DOI":"10.1016\/j.clae.2023.101819","volume":"46","author":"M Khan","year":"2023","unstructured":"Khan M, Ma K, Wan I, Willcox MD (2023) Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates. Cont Lens Anterior Eye 46(3):101819","journal-title":"Cont Lens Anterior Eye"},{"issue":"1\u20133","key":"5484_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0167-4781(98)00126-2","volume":"1400","author":"C Levine","year":"1998","unstructured":"Levine C, Hiasa H, Marians KJ (1998) DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta 1400(1\u20133):29\u201343","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5484_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","volume":"2","author":"A Fabrega","year":"2009","unstructured":"Fabrega A, Madurga S, Giralt E, Vila J (2009) Mechanism of action of and resistance to quinolones. Microb Biotechnol 2(1):40\u201361","journal-title":"Microb Biotechnol"},{"issue":"10","key":"5484_CR38","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochemistry 53(10):1565\u20131574","journal-title":"Biochemistry"},{"issue":"3","key":"5484_CR39","first-page":"377","volume":"61","author":"K Drlica","year":"1997","unstructured":"Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61(3):377\u2013392","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"5484_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1017\/S0033583598003424","volume":"31","author":"JC Wang","year":"1998","unstructured":"Wang JC (1998) Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine. Q Rev Biophys 31(2):107\u2013144","journal-title":"Q Rev Biophys"},{"issue":"1","key":"5484_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","volume":"1354","author":"DC Hooper","year":"2015","unstructured":"Hooper DC, Jacoby GA (2015) Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci 1354(1):12\u201331","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"5484_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.PLAS-0006-2013","volume":"2","author":"GA Jacoby","year":"2014","unstructured":"Jacoby GA, Strahilevitz J, Hooper DC (2014) Plasmid-mediated quinolone resistance. Microbiol Spectr 2(5):1\u201324","journal-title":"Microbiol Spectr"},{"issue":"2","key":"5484_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/IM9.0000000000000181","volume":"7","author":"B Hassen","year":"2025","unstructured":"Hassen B, Jouini A (2025) Fluoroquinolone-Resistant: Mechanisms of Resistance, Environmental Factors Influencing Resistance and Clinical Implications. Infect Microbes Dis 7(2):84\u201391","journal-title":"Infect Microbes Dis"},{"key":"5484_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1101\/cshperspect.a025320","volume":"6","author":"DC Hooper","year":"2016","unstructured":"Hooper DC, Jacoby GA (2016) Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. Cold Spring Harb Perspect Med 6:9","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6645","key":"5484_CR45","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/42294","volume":"388","author":"JHM Cabral","year":"1997","unstructured":"Cabral JHM, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC (1997) Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388(6645):903\u2013906","journal-title":"Nature"},{"issue":"9","key":"5484_CR46","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nsmb.1892","volume":"17","author":"A Wohlkonig","year":"2010","unstructured":"Wohlkonig A, Chan PF, Fosberry AP, Homes P, Huang J, Kranz M, Leydon VR, Miles TJ, Pearson ND, Perera RL, Shillings AJ, Gwynn MN, Bax BD (2010) Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 17(9):1152\u20131153","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"5484_CR47","doi-asserted-by":"publisher","first-page":"e0302352","DOI":"10.1371\/journal.pone.0302352","volume":"20","author":"MS Arefin","year":"2025","unstructured":"Arefin MS, Mitu MJ, Mitu SY, Nurjahan A, Mobin M, Nahar S, Anjum H, Rahman MH (2025) Mutational alterations in the QRDR regions associated with fluoroquinolone resistance in Pseudomonas aeruginosa of clinical origin from Savar, Dhaka. PLoS ONE 20(2):e0302352","journal-title":"PLoS ONE"},{"key":"5484_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817817","volume-title":"Quinolone antimicrobial agents","author":"DC Hooper","year":"2003","unstructured":"Hooper DC, Wolfson JS (2003) Quinolone antimicrobial agents, 3rd edn. American Society for Microbiology, Washington, DC","edition":"3"},{"issue":"11","key":"5484_CR49","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"K Drlica","year":"2009","unstructured":"Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X (2009) Quinolones: action and resistance updated. Curr Top Med Chem 9(11):981\u2013998","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"5484_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12866-024-03383-5","volume":"24","author":"S Rezaei","year":"2024","unstructured":"Rezaei S, Tajbakhsh S, Naeimi B, Yousefi F (2024) Investigation of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae clinical isolates. BMC Microbiol 24(1):265","journal-title":"BMC Microbiol"},{"issue":"1","key":"5484_CR51","first-page":"1386","volume":"8","author":"X Yang","year":"2015","unstructured":"Yang X, Xing B, Liang C, Ye Z, Zhang Y (2015) Prevalence and fluoroquinolone resistance of Pseudomonas aeruginosa in a hospital of South China. Int J Clin Exp Med 8(1):1386\u20131390","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"5484_CR52","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.bjm.2016.07.016","volume":"47","author":"R Nouri","year":"2016","unstructured":"Nouri R, Ahangarzadeh Rezaee M, Hasani A, Aghazadeh M, Asgharzadeh M (2016) The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran. Braz J Microbiol 47(4):925\u2013930","journal-title":"Braz J Microbiol"},{"issue":"4","key":"5484_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijantimicag.2004.11.012","volume":"25","author":"JK Lee","year":"2005","unstructured":"Lee JK, Lee YS, Park YK, Kim BS (2005) Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 25(4):290\u2013295","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"5484_CR54","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/bjo.87.10.1238","volume":"87","author":"JA Lomholt","year":"2003","unstructured":"Lomholt JA, Kilian M (2003) Ciprofloxacin susceptibility of Pseudomonas aeruginosa isolates from keratitis. Br J Ophthalmol 87(10):1238\u20131240","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"5484_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1089\/mdr.2018.0218","volume":"25","author":"K Thirumalmuthu","year":"2019","unstructured":"Thirumalmuthu K, Devarajan B, Prajna L, Mohankumar V (2019) Mechanisms of Fluoroquinolone and Aminoglycoside Resistance in Keratitis-Associated Pseudomonas aeruginosa. Microb Drug Resist 25(6):813\u2013823","journal-title":"Microb Drug Resist"},{"issue":"9","key":"5484_CR56","doi-asserted-by":"publisher","first-page":"e0204936","DOI":"10.1371\/journal.pone.0204936","volume":"13","author":"D Subedi","year":"2018","unstructured":"Subedi D, Vijay AK, Kohli GS, Rice SA, Willcox M (2018) Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa. PLoS ONE 13(9):e0204936","journal-title":"PLoS ONE"},{"issue":"7","key":"5484_CR57","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s10096-025-05132-6","volume":"44","author":"T Akter","year":"2025","unstructured":"Akter T, Stapleton F, Willcox M (2025) Differences in antimicrobial resistance between exoU and exoS isolates of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 44(7):1629\u20131641","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"5484_CR58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3947\/ic.2015.47.2.98","volume":"47","author":"M Adabi","year":"2015","unstructured":"Adabi M, Talebi-Taher M, Arbabi L, Afshar M, Fathizadeh S, Minaeian S, Moghadam-Maragheh N, Majidpour A (2015) Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor. Infect Chemother 47(2):98\u2013104","journal-title":"Infect Chemother"},{"issue":"9","key":"5484_CR59","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1128\/AAC.44.9.2233-2241.2000","volume":"44","author":"K Poole","year":"2000","unstructured":"Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44(9):2233\u20132241","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5484_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/jmm.0.000873","volume":"68","author":"A Rehman","year":"2019","unstructured":"Rehman A, Patrick WM, Lamont IL (2019) Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol 68(1):1\u201310","journal-title":"J Med Microbiol"},{"issue":"1","key":"5484_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.diagmicrobio.2004.05.004","volume":"50","author":"DJ Wolter","year":"2004","unstructured":"Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD (2004) Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagn Microbiol Infect Dis 50(1):43\u201350","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"5484_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","volume":"46","author":"A Nakajima","year":"2002","unstructured":"Nakajima A, Sugimoto Y, Yoneyama H, Nakae T (2002) High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation. Microbiol Immunol 46(6):391\u2013395","journal-title":"Microbiol Immunol"},{"issue":"9","key":"5484_CR63","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/antibiotics9090600","volume":"9","author":"M Khan","year":"2020","unstructured":"Khan M, Stapleton F, Summers S, Rice SA, Willcox MDP (2020) Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India. Antibiot (Basel) 9(9):600","journal-title":"Antibiot (Basel)"},{"key":"5484_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","volume":"29","author":"JM Rodriguez-Martinez","year":"2016","unstructured":"Rodriguez-Martinez JM, Machuca J, Cano ME, Calvo J, Martinez-Martinez L, Pascual A (2016) Plasmid-mediated quinolone resistance: Two decades on. Drug Resist Updat 29:13\u201329","journal-title":"Drug Resist Updat"},{"key":"5484_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmicb.2012.00024","volume":"3","author":"L Poirel","year":"2012","unstructured":"Poirel L, Cattoir V, Nordmann P (2012) Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies. Front Microbiol 3:24","journal-title":"Front Microbiol"},{"key":"5484_CR66","first-page":"11","volume":"13","author":"AS Tapia-Cornejo","year":"2024","unstructured":"Tapia-Cornejo AS, Ramirez-Castillo FY, Guerrero-Barrera AL, Guillen-Padilla DE, Arreola-Guerra JM, Gonzalez-Gamez M, Avelar-Gonzalez FJ, Loera-Muro A, Hernandez-Cuellar E, Ramos-Medellin CL, Adame-Alvarez C, Garcia-Romo R, Galindo-Guerrero F, Moreno-Flores AC (2024) Occurrence of Plasmid-Mediated Quinolone Resistance and Carbapenemase-Encoding Genes in Pseudomonas aeruginosa Isolates from Nosocomial Patients in Aguascalientes. Mexico Pathogens 13:11","journal-title":"Mexico Pathogens"},{"issue":"12","key":"5484_CR67","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1093\/jac\/dku308","volume":"69","author":"J Machuca","year":"2014","unstructured":"Machuca J, Briales A, Labrador G, Diaz-de-Alba P, Lopez-Rojas R, Docobo-Perez F, Martinez-Martinez L, Rodriguez-Bano J, Pachon ME, Pascual A, Rodriguez-Martinez JM (2014) Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother 69(12):3203\u20133215","journal-title":"J Antimicrob Chemother"},{"key":"5484_CR68","doi-asserted-by":"publisher","first-page":"1293443","DOI":"10.3389\/fmicb.2023.1293443","volume":"14","author":"L Mei","year":"2023","unstructured":"Mei L, Song Y, Liu D, Li Y, Liu L, Yu K, Jiang M, Wang D, Wei Q (2023) Characterization of a mobilizable megaplasmid carrying multiple resistance genes from a clinical isolate of Pseudomonas aeruginosa. Front Microbiol 14:1293443","journal-title":"Front Microbiol"},{"key":"5484_CR69","doi-asserted-by":"publisher","first-page":"104574","DOI":"10.1016\/j.meegid.2020.104574","volume":"85","author":"M Khan","year":"2020","unstructured":"Khan M, Summers S, Rice SA, Stapleton F, Willcox MDP, Subedi D (2020) Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa. Infect Genet Evol 85:104574","journal-title":"Infect Genet Evol"},{"issue":"1","key":"5484_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12866-024-03319-z","volume":"24","author":"SS Abdelrahim","year":"2024","unstructured":"Abdelrahim SS, Hassuna NA, Waly N, Kotb DN, Abdelhamid H, Zaki S (2024) Coexistence of plasmid-mediated quinolone resistance (PMQR) and extended-spectrum beta-lactamase (ESBL) genes among clinical Pseudomonas aeruginosa isolates in Egypt. BMC Microbiol 24(1):175","journal-title":"BMC Microbiol"},{"issue":"3","key":"5484_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.diagmicrobio.2014.03.025","volume":"79","author":"X Jiang","year":"2014","unstructured":"Jiang X, Yu T, Jiang X, Zhang W, Zhang L, Ma J (2014) Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan, China. Diagn Microbiol Infect Dis 79(3):381\u2013383","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5484_CR72","doi-asserted-by":"crossref","unstructured":"Chavez-Jacobo VM, Hernandez-Ramirez KC, Romo-Rodriguez P, Perez-Gallardo RV, Campos-Garcia J, Gutierrez-Corona JF, Garcia-Merinos JP, Meza-Carmen V, Silva-Sanchez J, Ramirez-Diaz MI (2018) CrpP Is a Novel Ciprofloxacin-Modifying Enzyme Encoded by the Pseudomonas aeruginosa pUM505 Plasmid. Antimicrob Agents Chemother 62(6):10\u20131128","DOI":"10.1128\/AAC.02629-17"},{"issue":"18","key":"5484_CR73","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","volume":"289","author":"A Mustaev","year":"2014","unstructured":"Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM, Drlica K (2014) Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding. J Biol Chem 289(18):12300\u201312312","journal-title":"J Biol Chem"},{"key":"5484_CR74","doi-asserted-by":"crossref","unstructured":"de la Ortiz JM, Nordmann P, Poirel L (2020) Pathogenicity Genomic Island-Associated CrpP-Like Fluoroquinolone-Modifying Enzymes among Pseudomonas aeruginosa Clinical Isolates in Europe. Antimicrob Agents Chemother 64(7):10\u20131128","DOI":"10.1128\/AAC.00489-20"},{"issue":"8","key":"5484_CR75","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/genes11080889","volume":"11","author":"J Botelho","year":"2020","unstructured":"Botelho J, Grosso F, Peixe L (2020) ICEs Are the Main Reservoirs of the Ciprofloxacin-Modifying crpP Gene in Pseudomonas aeruginosa. Genes (Basel) 11(8):889","journal-title":"Genes (Basel)"},{"issue":"1","key":"5484_CR76","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1080\/21505594.2021.1962160","volume":"12","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Yang H, Yin Z, Jing Y, Zhao Y, Fu H, Du H, Zhou D (2021) Diversification and prevalence of the quinolone resistance crpP genes and the crpP-carrying Tn 6786-related integrative and conjugative elements in Pseudomonas aeruginosa. Virulence 12(1):2162\u20132170","journal-title":"Virulence"},{"issue":"9","key":"5484_CR77","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/antibiotics11091271","volume":"11","author":"M Lopez","year":"2022","unstructured":"Lopez M, Rojo-Bezares B, Chichon G, Saenz Y (2022) Resistance to Fluoroquinolones in Pseudomonas aeruginosa from Human, Animal, Food and Environmental Origin: The Role of CrpP and Mobilizable ICEs. Antibiot (Basel) 11(9):1271","journal-title":"Antibiot (Basel)"},{"issue":"4","key":"5484_CR78","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s42770-021-00624-x","volume":"52","author":"MA Rather","year":"2021","unstructured":"Rather MA, Gupta K, Mandal M (2021) Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol 52(4):1701\u20131718","journal-title":"Braz J Microbiol"},{"key":"5484_CR79","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3389\/fmicb.2020.02057","volume":"11","author":"A Soares","year":"2020","unstructured":"Soares A, Alexandre K, Etienne M (2020) Tolerance and Persistence of Pseudomonas aeruginosa in Biofilms Exposed to Antibiotics: Molecular Mechanisms, Antibiotic Strategies and Therapeutic Perspectives. Front Microbiol 11:2057","journal-title":"Front Microbiol"},{"issue":"1","key":"5484_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2415-13-57","volume":"13","author":"SH Abidi","year":"2013","unstructured":"Abidi SH, Sherwani SK, Siddiqui TR, Bashir A, Kazmi SU (2013) Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol 13(1):57","journal-title":"BMC Ophthalmol"},{"issue":"Pt 12","key":"5484_CR81","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1099\/jmm.0.2008\/003723-0","volume":"57","author":"MH Choy","year":"2008","unstructured":"Choy MH, Stapleton F, Willcox MDP, Zhu H (2008) Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. J Med Microbiol 57(Pt 12):1539\u20131546","journal-title":"J Med Microbiol"},{"issue":"7","key":"5484_CR82","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1128\/JB.01231-09","volume":"192","author":"N Moker","year":"2010","unstructured":"Moker N, Dean CR, Tao J (2010) Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 192(7):1946\u20131955","journal-title":"J Bacteriol"},{"key":"5484_CR83","doi-asserted-by":"publisher","first-page":"12958","DOI":"10.3389\/bjbs.2024.12958","volume":"81","author":"AP Kunnath","year":"2024","unstructured":"Kunnath AP, Suodha Suoodh M, Chellappan DK, Chellian J, Palaniveloo K (2024) Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update. Br J Biomed Sci 81:12958","journal-title":"Br J Biomed Sci"},{"issue":"10","key":"5484_CR84","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/ph16101353","volume":"16","author":"S Rivetti","year":"2023","unstructured":"Rivetti S, Romano A, Mastrangelo S, Attina G, Maurizi P, Ruggiero A (2023) Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients. Pharmaceuticals (Basel) 16(10):1353","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"5484_CR85","doi-asserted-by":"publisher","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","volume":"6","author":"KM Krause","year":"2016","unstructured":"Krause KM, Serio AW, Kane TR, Connolly LE (2016) Aminoglycosides: An Overview. Cold Spring Harb Perspect Med 6(6):a027029","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5484_CR86","doi-asserted-by":"crossref","unstructured":"Wang N, Luo J, Deng F, Huang Y, Zhou H (2022) Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics. Front Pharmacol. Frontiers Media S.A","DOI":"10.3389\/fphar.2022.839808"},{"issue":"1","key":"5484_CR87","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1186\/s12879-024-09605-5","volume":"24","author":"MR Boushra","year":"2024","unstructured":"Boushra MR, Gad GFM, Hassuna NA, Waly NGF, Ibrahem RA (2024) Phenotypic and genotypic assessment of fluoroquinolones and aminoglycosides resistances in Pseudomonas aeruginosa collected from Minia hospitals, Egypt during COVID-19 pandemic. BMC Infect Dis 24(1):763","journal-title":"BMC Infect Dis"},{"key":"5484_CR88","unstructured":"Meletis G, Karastergiou E (2025) Resistance mechanisms and therapeutic strategies for Pseudomonas aeruginosa infections. Ther Adv Infect Dis. SAGE Publications Ltd"},{"issue":"5","key":"5484_CR89","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1369-5274(99)00007-7","volume":"2","author":"GD Wright","year":"1999","unstructured":"Wright GD (1999) Aminoglycoside-modifying enzymes. Curr Opin Microbiol 2(5):499\u2013503","journal-title":"Curr Opin Microbiol"},{"key":"5484_CR90","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jtos.2025.10.011","volume":"38","author":"A Tigabu","year":"2025","unstructured":"Tigabu A, Willcox MDP, Stapleton F (2025) Phenotypic and genotypic profiling of antimicrobial resistance genes and virulence factors in Pseudomonas aeruginosa isolates from keratitis patients. Ocul Surf 38:392\u2013420","journal-title":"Ocul Surf"},{"key":"5484_CR91","doi-asserted-by":"publisher","first-page":"108504","DOI":"10.1016\/j.exer.2021.108504","volume":"205","author":"M Khan","year":"2021","unstructured":"Khan M, Willcox MDP, Rice SA, Sharma S, Stapleton F (2021) Development of antibiotic resistance in the ocular Pseudomonas aeruginosa clone ST308 over twenty years. Exp Eye Res 205:108504","journal-title":"Exp Eye Res"},{"key":"5484_CR92","doi-asserted-by":"crossref","unstructured":"Eichenberger EM, Thaden JT (2019) Epidemiology and mechanisms of resistance of extensively drug resistant gram-negative bacteria. Antibiotics. MDPI AG","DOI":"10.3390\/antibiotics8020037"},{"issue":"12","key":"5484_CR93","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1093\/gbe\/evx243","volume":"9","author":"T Miyoshi-Akiyama","year":"2017","unstructured":"Miyoshi-Akiyama T, Tada T, Ohmagari N, Viet Hung N, Tharavichitkul P, Pokhrel BM, Gniadkowski M, Shimojima M, Kirikae T (2017) Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa. Genome Biol Evol 9(12):3238\u20133245","journal-title":"Genome Biol Evol"},{"key":"5484_CR94","doi-asserted-by":"crossref","unstructured":"Morita Y, Tomida J, Kawamura Y (2012) Mexxy multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol. Frontiers Research Foundation","DOI":"10.3389\/fmicb.2012.00408"},{"key":"5484_CR95","unstructured":"Wu W, Huang J, Xu Z (2024) Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications. Microbial Biotechnol. John Wiley and Sons Ltd"},{"issue":"3","key":"5484_CR96","doi-asserted-by":"publisher","first-page":"e0508722","DOI":"10.1128\/spectrum.05087-22","volume":"11","author":"G Atassi","year":"2023","unstructured":"Atassi G, Medernach R, Scheetz M, Nozick S, Rhodes NJ, Murphy-Belcaster M, Murphy KR, Alisoltani A, Ozer EA, Hauser AR (2023) Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital. Microbiol Spectr 11(3):e0508722","journal-title":"Microbiol Spectr"},{"issue":"10","key":"5484_CR97","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01044-19","volume":"63","author":"A Bolard","year":"2019","unstructured":"Bolard A, Schniederjans M, Ha\u00fcssler S, Triponney P, Valot B, Pl\u00e9siat P, Jeannot K (2019) Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 63(10):10\u20131128","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5484_CR98","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3390\/microorganisms11092293","volume":"11","author":"SW El-Far","year":"2023","unstructured":"El-Far SW, Abukhatwah MW (2023) Prevalence of Aminoglycoside Resistance Genes in Clinical Isolates of Pseudomonas aeruginosa from Taif, Saudi Arabia-An Emergence Indicative Study. Microorganisms 11(9):2293","journal-title":"Microorganisms"},{"issue":"2","key":"5484_CR99","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/cxo.12621","volume":"101","author":"D Subedi","year":"2018","unstructured":"Subedi D, Vijay AK, Willcox M (2018) Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clin Exp Optom 101(2):162\u2013171","journal-title":"Clin Exp Optom"},{"key":"5484_CR100","doi-asserted-by":"crossref","unstructured":"Mammeri H, Sereme Y, Toumi E, Faury H, Skurnik D (2025) Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae. PLoS Pathogens. Public Library of Science","DOI":"10.1371\/journal.ppat.1012902"},{"key":"5484_CR101","doi-asserted-by":"crossref","unstructured":"Hardie Boys MT, Pletzer D (2025) A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents. Elsevier B.V","DOI":"10.1016\/j.ijantimicag.2025.107527"},{"key":"5484_CR102","doi-asserted-by":"crossref","unstructured":"Zhao DW, Lohans CT (2025) Combatting Pseudomonas aeruginosa with \u03b2-Lactam Antibiotics: A Revived Weapon? Antibiotics. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/antibiotics14050526"},{"issue":"4","key":"5484_CR103","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/microorganisms13040913","volume":"13","author":"M Hu","year":"2025","unstructured":"Hu M, Chua SL (2025) Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies. Microorganisms 13(4):913","journal-title":"Microorganisms"},{"key":"5484_CR104","volume-title":"Cephalosporins","author":"T Bui","year":"2025","unstructured":"Bui T, Patel P, Preuss CV (2025) Cephalosporins. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"issue":"4","key":"5484_CR105","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.xops.2023.100452","volume":"4","author":"EG Romanowski","year":"2024","unstructured":"Romanowski EG, Mumper SM, Shanks HQ, Yates KA, Mandell JB, Zegans ME, Shanks RMQ (2024) Cefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. Ophthalmol Sci 4(4):100452","journal-title":"Ophthalmol Sci"},{"issue":"10","key":"5484_CR106","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/antibiotics13100979","volume":"13","author":"EG Romanowski","year":"2024","unstructured":"Romanowski EG, Mandell JB, Jhanji V, Shanks RMQ (2024) The Efficacy of Topical Cefiderocol Treatment of Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis Is Dependent upon the State of the Corneal Epithelium. Antibiotics 13(10):979","journal-title":"Antibiotics"},{"key":"5484_CR107","doi-asserted-by":"crossref","unstructured":"Velcani F, Kuo IC, Shanks RM, Chodosh J, Garg P, Amescua G, Zegans ME (2023) Association of artificial tears with ocular and systemic infection: carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) outbreak. Ophthalmol130 (11):1118","DOI":"10.1016\/j.ophtha.2023.06.003"},{"key":"5484_CR108","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2147\/IDR.S174570","volume":"11","author":"M Hogan","year":"2018","unstructured":"Hogan M, Bridgeman MB, Min GH, Dixit D, Bridgeman PJ, Narayanan N (2018) Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections. Infect Drug Resist 11:1975\u20131981","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5484_CR109","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12866-025-03935-3","volume":"25","author":"M Wang","year":"2025","unstructured":"Wang M, Zhang Y, Pei F, Liu Y, Zheng Y (2025) Loss of OprD function is sufficient for carbapenem-resistance-only but insufficient for multidrug resistance in Pseudomonas aeruginosa. BMC Microbiol 25(1):218","journal-title":"BMC Microbiol"},{"issue":"12","key":"5484_CR110","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/pathogens10121638","volume":"10","author":"KA Glen","year":"2021","unstructured":"Glen KA, Lamont IL (2021) beta-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects. Pathogens 10(12):1638","journal-title":"Pathogens"},{"issue":"1","key":"5484_CR111","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40560-020-0429-6","volume":"8","author":"T Sawa","year":"2020","unstructured":"Sawa T, Kooguchi K, Moriyama K (2020) Molecular diversity of extended-spectrum beta-lactamases and carbapenemases, and antimicrobial resistance. J Intensive Care 8(1):13","journal-title":"J Intensive Care"},{"key":"5484_CR112","doi-asserted-by":"crossref","unstructured":"Fratoni AJ, Gethers ML, Nicolau DP, Kuti JL (2024) Non-KPC Attributes of Newer \u03b2-lactam\/\u03b2-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa. Clin Infect Dis 79(1):33\u201342","DOI":"10.1093\/cid\/ciae048"},{"issue":"6","key":"5484_CR113","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/jac\/dkv004","volume":"70","author":"SD Lahiri","year":"2015","unstructured":"Lahiri SD, Walkup GK, Whiteaker JD, Palmer T, McCormack K, Tanudra MA, Nash TJ, Thresher J, Johnstone MR, Hajec L, Livchak S, McLaughlin RE, Alm RA (2015) Selection and molecular characterization of ceftazidime\/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC. J Antimicrob Chemother 70(6):1650\u20131658","journal-title":"J Antimicrob Chemother"},{"key":"5484_CR114","doi-asserted-by":"crossref","unstructured":"Jacoby GA (2009) AmpC \u0392-Lactamases. Clinical Microbiology Reviews, pp 161\u2013182","DOI":"10.1128\/CMR.00036-08"},{"key":"5484_CR115","unstructured":"CDC (2023) Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears. CDC"},{"key":"5484_CR116","doi-asserted-by":"crossref","unstructured":"Alimoghadam S, Eslami A, Alimoghadam R, Bahrami Mianrood I, Azizmohammad Looha M, Khodadadi S, Shokouhi S, Alavi Darazam I (2024) The frequency of AmpC overproduction, OprD downregulation and OprM efflux pump expression in Pseudomonas aeruginosa: A comprehensive meta-analysis. J Glob Antimicrob Resist. Elsevier Ltd, pp 159\u2013169","DOI":"10.1016\/j.jgar.2024.08.014"},{"issue":"2","key":"5484_CR117","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/microorganisms8020260","volume":"8","author":"A Dave","year":"2020","unstructured":"Dave A, Samarth A, Karolia R, Sharma S, Karunakaran E, Partridge L, MacNeil S, Monk PN, Garg P, Roy S (2020) Characterization of Ocular Clinical Isolates of Pseudomonas aeruginosa from Non-Contact Lens Related Keratitis Patients from South India. Microorganisms 8(2):260","journal-title":"Microorganisms"},{"issue":"11","key":"5484_CR118","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/antibiotics14111167","volume":"14","author":"I Osei Duah Junior","year":"2025","unstructured":"Osei Duah Junior I, Ampong J, Danquah CA (2025) Mechanisms and Evolution of Antimicrobial Resistance in Ophthalmology: Surveillance, Clinical Implications, and Future Therapies. Antibiot (Basel) 14(11):1167","journal-title":"Antibiot (Basel)"},{"key":"5484_CR119","doi-asserted-by":"crossref","unstructured":"Dzi\u0119gielewska M, Tomczyk M, Wiater A, Woyto\u0144 A, Junka A (2025) Targeting Ocular Biofilms with Plant-Derived Antimicrobials in the Era of Antibiotic Resistance. Molecules. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/molecules30132863"},{"key":"5484_CR120","doi-asserted-by":"crossref","unstructured":"Schwartz B, Klamer K, Zimmerman J, Kale-Pradhan PB, Bhargava A (2024) Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies. Pathogens. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/pathogens13110975"},{"issue":"4","key":"5484_CR121","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1128\/AAC.48.4.1175-1187.2004","volume":"48","author":"N Bagge","year":"2004","unstructured":"Bagge N, Schuster M, Hentzer M, Ciofu O, Givskov M, Greenberg EP, Hoiby N (2004) Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 48(4):1175\u20131187","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5484_CR122","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jfo.2018.01.012","volume":"41","author":"H Heidari","year":"2018","unstructured":"Heidari H, Hadadi M, Ebrahim-Saraie HS, Mirzaei A, Taji A, Hosseini S, Motamedifar M (2018) Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection. J Fr Ophtalmol 41(9):823\u2013829","journal-title":"J Fr Ophtalmol"},{"issue":"6","key":"5484_CR123","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/jac\/dky073","volume":"73","author":"D Subedi","year":"2018","unstructured":"Subedi D, Vijay AK, Kohli GS, Rice SA, Willcox M (2018) Nucleotide sequence analysis of NPS-1 beta-lactamase and a novel integron (In1427)-carrying transposon in an MDR Pseudomonas aeruginosa keratitis strain. J Antimicrob Chemother 73(6):1724\u20131726","journal-title":"J Antimicrob Chemother"},{"key":"5484_CR124","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.micres.2016.10.002","volume":"193","author":"N Murugan","year":"2016","unstructured":"Murugan N, Malathi J, Umashankar V, Madhavan H (2016) Unraveling genomic and phenotypic nature of multidrug-resistant (MDR) Pseudomonas aeruginosa VRFPA04 isolated from keratitis patient. Microbiol Res 193:140\u2013149","journal-title":"Microbiol Res"},{"key":"5484_CR125","doi-asserted-by":"crossref","unstructured":"Benedict R, Langlykke A (1947) Antibiotic activity of Bacillus polymyxa","DOI":"10.1146\/annurev.mi.01.100147.001205"},{"key":"5484_CR126","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-3-030-16373-0_20","volume":"1145","author":"T Velkov","year":"2019","unstructured":"Velkov T, Roberts KD (2019) Discovery of Novel Polymyxin-Like Antibiotics. Adv Exp Med Biol 1145:343\u2013362","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"5484_CR127","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12038-021-00209-8","volume":"46","author":"SS Mohapatra","year":"2021","unstructured":"Mohapatra SS, Dwibedy SK, Padhy I (2021) Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. J Biosci 46(3):85","journal-title":"J Biosci"},{"key":"5484_CR128","doi-asserted-by":"publisher","first-page":"1424765","DOI":"10.3389\/fphar.2024.1424765","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang S, Wang H, Zhao D, Zhang S, Hu C (2024) Polymyxins: recent advances and challenges. Front Pharmacol 15:1424765","journal-title":"Front Pharmacol"},{"issue":"10","key":"5484_CR129","doi-asserted-by":"publisher","first-page":"a025288","DOI":"10.1101\/cshperspect.a025288","volume":"6","author":"MJ Trimble","year":"2016","unstructured":"Trimble MJ, Mlyn\u00e1r\u010dik P, Kol\u00e1\u0159 M, Hancock RE (2016) Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harbor Perspect Med 6(10):a025288","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"2","key":"5484_CR130","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30(2):557\u2013596","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"5484_CR131","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1021\/acschembio.7b00836","volume":"13","author":"M-L Han","year":"2018","unstructured":"Han M-L, Velkov T, Zhu Y, Roberts KD, Le Brun AP, Chow SH, Gutu AD, Moskowitz SM, Shen H-H, Li J (2018) Polymyxin-induced lipid A deacylation in Pseudomonas aeruginosa perturbs polymyxin penetration and confers high-level resistance. ACS Chem Biol 13(1):121\u2013130","journal-title":"ACS Chem Biol"},{"issue":"2","key":"5484_CR132","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/JB.186.2.575-579.2004","volume":"186","author":"SM Moskowitz","year":"2004","unstructured":"Moskowitz SM, Ernst RK, Miller SI (2004) PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol 186(2):575\u2013579","journal-title":"J Bacteriol"},{"key":"5484_CR133","doi-asserted-by":"crossref","unstructured":"Moffatt JH, Harper M, Boyce JD (2019) Mechanisms of polymyxin resistance. Polymyxin antibiotics: From laboratory bench to bedside:55\u201371","DOI":"10.1007\/978-3-030-16373-0_5"},{"issue":"1","key":"5484_CR134","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1365-2958.2003.03673.x","volume":"50","author":"JB McPhee","year":"2003","unstructured":"McPhee JB, Lewenza S, Hancock RE (2003) Cationic antimicrobial peptides activate a two-component regulatory system, PmrA\u2010PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50(1):205\u2013217","journal-title":"Mol Microbiol"},{"issue":"4\u20135","key":"5484_CR135","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drup.2010.05.002","volume":"13","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Rafailidis PI, Matthaiou DK (2010) Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 13(4\u20135):132\u2013138","journal-title":"Drug Resist Updat"},{"issue":"1","key":"5484_CR136","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5507\/bp.2018.070","volume":"163","author":"P Mlynarcik","year":"2019","unstructured":"Mlynarcik P, Kolar M (2019) Molecular mechanisms of polymyxin resistance and detection of mcr genes. Biomedical Papers Med Fac Palacky Univ Olomouc 163(1):28\u201338","journal-title":"Biomedical Papers Med Fac Palacky Univ Olomouc"},{"issue":"3","key":"5484_CR137","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1128\/AAC.01252-10","volume":"55","author":"C Muller","year":"2011","unstructured":"Muller C, Pl\u00e9siat P, Jeannot K (2011) A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and \u03b2-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55(3):1211\u20131221","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5484_CR138","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1128\/AAC.00242-10","volume":"54","author":"L Fern\u00e1ndez","year":"2010","unstructured":"Fern\u00e1ndez L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock RE (2010) Adaptive resistance to the last hope antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother 54(8):3372\u20133382","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5484_CR139","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1128\/AAC.02353-12","volume":"57","author":"AD Gutu","year":"2013","unstructured":"Gutu AD, Sgambati N, Strasbourger P, Brannon MK, Jacobs MA, Haugen E, Kaul RK, Johansen HK, H\u00f8iby N, Moskowitz SM (2013) Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. Antimicrob Agents Chemother 57(5):2204\u20132215","journal-title":"Antimicrob Agents Chemother"},{"issue":"21","key":"5484_CR140","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.3390\/ijms262110499","volume":"26","author":"MA Damtie","year":"2025","unstructured":"Damtie MA, Vijay AK, Willcox MDP (2025) Detection of Genes Associated with Polymyxin and Antimicrobial Peptide Resistance in Isolates of Pseudomonas aeruginosa. Int J Mol Sci 26(21):10499","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5484_CR141","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2016","unstructured":"Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16(2):161\u2013168","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5484_CR142","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1128\/AAC.00066-16","volume":"60","author":"K Zurfuh","year":"2016","unstructured":"Zurfuh K, Poirel L, Nordmann P, N\u00fcesch-Inderbinen M, H\u00e4chler H, Stephan R (2016) Occurrence of the plasmid-borne mcr-1 colistin resistance gene in extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae in river water and imported vegetable samples in Switzerland. Antimicrob Agents Chemother 60(4):2594\u20132595","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5484_CR143","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/1040841X.2018.1492902","volume":"45","author":"SC Nang","year":"2019","unstructured":"Nang SC, Li J, Velkov T (2019) The rise and spread of mcr plasmid-mediated polymyxin resistance. Crit Rev Microbiol 45(2):131\u2013161","journal-title":"Crit Rev Microbiol"},{"key":"5484_CR144","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.sbi.2023.102647","volume":"82","author":"IC Materon","year":"2023","unstructured":"Materon IC, Palzkill T (2023) Structural biology of MCR-1-mediated resistance to polymyxin antibiotics. Curr Opin Struct Biol 82:102647","journal-title":"Curr Opin Struct Biol"},{"issue":"12","key":"5484_CR145","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1074\/jbc.RA117.000924","volume":"293","author":"Y Xu","year":"2018","unstructured":"Xu Y, Lin J, Cui T, Srinivas S, Feng Y (2018) Mechanistic insights into transferable polymyxin resistance among gut bacteria. J Biol Chem 293(12):4350\u20134365","journal-title":"J Biol Chem"},{"issue":"1","key":"5484_CR146","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12941-025-00799-3","volume":"24","author":"A Azzam","year":"2025","unstructured":"Azzam A, Salem H, Nazih M, Lotfy EM, Hassan FE, Khaled H (2025) Prevalence, trends, and molecular insights into colistin resistance among gram-negative bacteria in Egypt: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob 24(1):32","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5484_CR147","doi-asserted-by":"crossref","unstructured":"Shahzad S, Willcox MDP, Rayamajhee B (2023) A Review of Resistance to Polymyxins and Evolving Mobile Colistin Resistance Gene (mcr) among Pathogens of Clinical Significance. Antibiotics (Basel) 12 (11)","DOI":"10.3390\/antibiotics12111597"},{"key":"5484_CR148","doi-asserted-by":"publisher","DOI":"10.4103\/ohbl.ohbl_4135_4125","author":"PK Gautam","year":"2025","unstructured":"Gautam PK, Prajapati B, Tiwari ON (2025) Colistin resistance and the mcr-1 gene of Pseudomonas aeruginosa: Insights from Indian clinical isolates. One Health Bull. https:\/\/doi.org\/10.4103\/ohbl.ohbl_4135_4125","journal-title":"One Health Bull"},{"issue":"1","key":"5484_CR149","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s43856-025-01109-w","volume":"5","author":"OO Ikhimiukor","year":"2025","unstructured":"Ikhimiukor OO, Montoya-Giraldo M, Souza SSR, Akintayo IJ, Zac Soligno NI, Marmion M, Eckhardt EM, Carreiro N, Workman AA, Martin IW, Andam CP (2025) Dissemination dynamics of colistin resistance genes mcr-9 and mcr-10 across diverse Inc plasmid backbones. Commun Med (Lond) 5(1):399","journal-title":"Commun Med (Lond)"},{"issue":"12","key":"5484_CR150","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1093\/jac\/dkae344","volume":"79","author":"Y Huang","year":"2024","unstructured":"Huang Y, Liao M, Hu X, Hu H, Gong H (2024) Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins. J Antimicrob Chemother 79(12):3210\u20133229","journal-title":"J Antimicrob Chemother"},{"key":"5484_CR151","doi-asserted-by":"publisher","unstructured":"Lin J, Xu C, Fang R, Cao J, Zhang X, Zhao Y, Dong G, Sun Y, Zhou T (2019) Resistance and heteroresistance to colistin in Pseudomonas aeruginosa isolates from Wenzhou, China. Antimicrob Agents Chemother 63(10). https:\/\/doi.org\/10.1128\/aac00556\u2009\u2013\u200900519","DOI":"10.1128\/aac"},{"key":"5484_CR152","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/microorganisms8111647","volume":"8","author":"A Amsalu","year":"2020","unstructured":"Amsalu A, Sapula SA, De Barros Lopes M, Hart BJ, Nguyen AH, Drigo B, Turnidge J, Leong LE, Venter H (2020) Efflux Pump-Driven Antibiotic and Biocide Cross-Resistance in Pseudomonas aeruginosa Isolated from Different Ecological Niches: A Case Study in the Development of Multidrug Resistance in Environmental Hotspots. Microorganisms 8:11","journal-title":"Microorganisms"},{"issue":"1","key":"5484_CR153","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12866-024-03309-1","volume":"24","author":"S Jafari-Ramedani","year":"2024","unstructured":"Jafari-Ramedani S, Nazari M, Arzanlou M, Peeri-Dogaheh H, Sahebkar A, Khademi F (2024) Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals. BMC Microbiol 24(1):152","journal-title":"BMC Microbiol"},{"issue":"6","key":"5484_CR154","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2021-320203","volume":"107","author":"S Sahoo","year":"2023","unstructured":"Sahoo S, Alluri H, Mitra S, Priyadarshini S, Sahu SK, Mohanty A, Das S (2023) Multidrug-resistant keratitis: challenging yet manageable. Br J Ophthalmol 107(6):769\u2013773","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"5484_CR155","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0301-4738.179721","volume":"64","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Agrawal D (2016) Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate. Indian J Ophthalmol 64(2):153\u2013157","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"5484_CR156","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.4103\/ijo.IJO_678_19","volume":"67","author":"M Acharya","year":"2019","unstructured":"Acharya M, Farooqui JH, Singh A, Gandhi A, Mathur U (2019) Bacterial isolates in microbial keratitis: Three-year trend analysis from North India. Indian J Ophthalmol 67(9):1508\u20131509","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"5484_CR157","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","volume":"106","author":"P Garg","year":"1999","unstructured":"Garg P, Sharma S, Rao GN (1999) Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmol 106(7):1319\u20131323","journal-title":"Ophthalmol"},{"issue":"3","key":"5484_CR158","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/09273948.2014.883545","volume":"23","author":"S Gupta","year":"2015","unstructured":"Gupta S, Mittal S, Nayak N, Satpathy G, Khokhar S, Agarwal T (2015) In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates. Ocul Immunol Inflamm 23(3):252\u2013255","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"5484_CR159","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.4103\/ijo.IJO_1438_22","volume":"70","author":"A Khurana","year":"2022","unstructured":"Khurana A, Chatterjee S, Gandhi A, Borde P, Chanda S, Gomase SN, Aggarwal M, Parmar GS, Majumdar A, Podder P (2022) Antibiotic susceptibility pattern of bacterial isolates from microbial keratitis in North and Central India: A multi centric study. Indian J Ophthalmol 70(12):4263\u20134269","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"5484_CR160","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0161-6420(99)90008-8","volume":"106","author":"DY Kunimoto","year":"1999","unstructured":"Kunimoto DY, Sharma S, Garg P, Rao GN (1999) In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmol 106(1):80\u201385","journal-title":"Ophthalmol"},{"issue":"6","key":"5484_CR161","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4103\/ijo.IJO_2070_22","volume":"71","author":"GS Parmar","year":"2023","unstructured":"Parmar GS, Meena AK, Borde P, Prasad S (2023) Microbial keratitis and antibiotic sensitivity patterns: A retrospective analysis at a tertiary center in Central India. Indian J Ophthalmol 71(6):2455\u20132459","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"5484_CR162","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/0301-4738.98702","volume":"60","author":"A Tewari","year":"2012","unstructured":"Tewari A, Sood N, Vegad MM, Mehta DC (2012) Epidemiological and microbiological profile of infective keratitis in Ahmedabad. Indian J Ophthalmol 60(4):267\u2013272","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"5484_CR163","first-page":"131","volume":"7","author":"N Rahim","year":"2008","unstructured":"Rahim N, Bano H, Naqvi B (2008) Sensitivity pattern of bacteria isolated from contact lens wearers in the faculty of pharmacy, Karachi University student population. Iran J Pharm Res 7(2):131\u2013134","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"5484_CR164","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10792-024-03270-y","volume":"44","author":"WB Khor","year":"2024","unstructured":"Khor WB, Lakshminarayanan R, Periayah MH, Prajna VN, Garg P, Sharma N, Mehta JS, Young A, Goseyarakwong P, Puangsricharern V, Tan AL, Beuerman RW, Tan DT, Acsiks G (2024) The antibiotic resistance profiles of Pseudomonas aeruginosa in the Asia Cornea Society Infectious Keratitis Study. Int Ophthalmol 44(1):361","journal-title":"Int Ophthalmol"},{"issue":"8","key":"5484_CR165","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/aos.14789","volume":"99","author":"S Xu","year":"2021","unstructured":"Xu S, Guo D, Liu X, Jin X, Shi Y, Wang Y, Zhang N, Zhang H (2021) Ocular pathogens and antibiotic resistance in microbial keratitis over three years in Harbin, Northeast China. Acta Ophthalmol 99(8):909\u2013915","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"5484_CR166","first-page":"8","volume":"99","author":"PE Valianto","year":"2022","unstructured":"Valianto PE, Wasito EB, Koendhori EB, Zuhria I (2022) Profile of Pseudomonas aeruginosa Antibiotic Sensitivity Test Results from Corneal Scrapings Specimens of Keratitis Patients with Contact Lens Users and Non-Contact Lenses Users at Dr. Soetomo Hosp Surabaya 99(1):8\u20138","journal-title":"Soetomo Hosp Surabaya"},{"issue":"3","key":"5484_CR167","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4103\/0974-9233.84053","volume":"18","author":"M Mohammadpour","year":"2011","unstructured":"Mohammadpour M, Mohajernezhadfard Z, Khodabande A, Vahedi P (2011) Antibiotic susceptibility patterns of pseudomonas corneal ulcers in contact lens wearers. Middle East Afr J Ophthalmol 18(3):228\u2013231","journal-title":"Middle East Afr J Ophthalmol"},{"key":"5484_CR168","unstructured":"Goudarzi H, Karimi F, Amoli FA, Abedinyfar Z, Doustdar F, Mehrnejad F (2011) Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa isolates from eye infections"},{"issue":"7","key":"5484_CR169","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10792-018-0980-5","volume":"39","author":"F Doustdar","year":"2019","unstructured":"Doustdar F, Karimi F, Abedinyfar Z, Amoli FA, Goudarzi H (2019) Genetic features of Pseudomonas aeruginosa isolates associated with eye infections referred to Farabi Hospital, Tehran, Iran. Int Ophthalmol 39(7):1581\u20131587","journal-title":"Int Ophthalmol"},{"key":"5484_CR170","doi-asserted-by":"crossref","unstructured":"Oliveira-Ferreira C, Leuzinger-Dias M, Tavares-Ferreira J, Torrao L, Falcao-Reis F (2019) Microbiological Profile of Infectious Keratitis in a Portuguese Tertiary Centre. J Ophthalmol 2019:6328058","DOI":"10.1155\/2019\/6328058"},{"issue":"1","key":"5484_CR171","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/ICL.0000000000000298","volume":"44","author":"CS Ferreira","year":"2018","unstructured":"Ferreira CS, Figueira L, Moreira-Goncalves N, Moreira R, Torrao L, Falcao-Reis F (2018) Clinical and Microbiological Profile of Bacterial Microbial Keratitis in a Portuguese Tertiary Referral Center-Where Are We in 2015? Eye Contact Lens 44(1):15\u201320","journal-title":"Eye Contact Lens"},{"issue":"6","key":"5484_CR172","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/ICL.0000000000000883","volume":"48","author":"J Lorente Pascua","year":"2022","unstructured":"Lorente Pascua J, Garcia Bernal A, Garcia Sanchez E, Almeida Gonzalez CV (2022) Microorganisms and Antibiotic Resistance of Bacterial Keratitis at a Rural County Hospital in Seville. Eye Contact Lens 48(6):267\u2013271","journal-title":"Eye Contact Lens"},{"issue":"7","key":"5484_CR173","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.eimc.2017.08.002","volume":"36","author":"S Mediero","year":"2018","unstructured":"Mediero S, Boto de Los Bueis A, Spiess K, Diaz-Almiron M, Del Hierro Zarzuelo A, Villalain Rodes I, Garcia Perea A (2018) Clinical and microbiological profile of infectious keratitis in an area of Madrid, Spain. Enferm Infecc Microbiol Clin (Engl Ed) 36(7):409\u2013416","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"1","key":"5484_CR174","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/ICO.0000000000001417","volume":"37","author":"MY Peng","year":"2018","unstructured":"Peng MY, Cevallos V, McLeod SD, Lietman TM, Rose-Nussbaumer J (2018) Bacterial Keratitis: Isolated Organisms and Antibiotic Resistance Patterns in San Francisco. Cornea 37(1):84\u201387","journal-title":"Cornea"},{"issue":"12","key":"5484_CR175","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/ICO.0000000000003198","volume":"42","author":"L Kang","year":"2023","unstructured":"Kang L, Lu MC, Niziol LM, Greenwald MF, Mian SI, Thibodeau A, Pawar M, Lephart PR, Woodward MA (2023) Microbial Keratitis Isolates at a Midwestern Tertiary Eye Care Center. Cornea 42(12):1488\u20131496","journal-title":"Cornea"},{"issue":"5","key":"5484_CR176","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.11.5.26","volume":"11","author":"JA Mei","year":"2022","unstructured":"Mei JA, Johnson W, Kinn B, Laskey E, Nolin L, Bhamare P, Stalker C, Dunman PM, Wozniak RAF (2022) Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates. Transl Vis Sci Technol 11(5):26","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"5484_CR177","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamaophthalmol.2024.0259","volume":"142","author":"FE Tribin","year":"2024","unstructured":"Tribin FE, Lieux C, Maestre-Mesa J, Durkee H, Krishna K, Chou B, Neag E, Tothova JD, Martinez JD, Flynn HW Jr., Parel JM, Miller D, Amescua G (2024) Clinical Features and Treatment Outcomes of Carbapenem-Resistant Pseudomonas aeruginosa Keratitis. JAMA Ophthalmol 142(5):407\u2013415","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"5484_CR178","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/02713680500536746","volume":"31","author":"H Zhu","year":"2006","unstructured":"Zhu H, Conibear TC, Bandara R, Aliwarga Y, Stapleton F, Willcox MD (2006) Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res 31(4):297\u2013306","journal-title":"Curr Eye Res"},{"key":"5484_CR179","doi-asserted-by":"crossref","unstructured":"Watson SL, Gatus BJ, Cabrera-Aguas M, Armstrong BH, George CR, Khoo P, Lahra MM (2020) Bacterial Ocular Surveillance System (BOSS) Sydney, Australia 2017\u20132018. Commun Dis Intell (2018) 44","DOI":"10.33321\/cdi.2020.44.86"},{"issue":"2","key":"5484_CR180","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/bjophthalmol-2016-308487","volume":"101","author":"P Lalitha","year":"2017","unstructured":"Lalitha P, Manoharan G, Karpagam R, Prajna NV, Srinivasan M, Mascarenhas J, Das M, Porco TC, Lietman TM, Cevallos V, Keenan JD (2017) Trends in antibiotic resistance in bacterial keratitis isolates from South India. Br J Ophthalmol 101(2):108\u2013113","journal-title":"Br J Ophthalmol"},{"key":"5484_CR181","doi-asserted-by":"crossref","unstructured":"Kaliamurthy J, Kalavathy CM, Parmar P, Nelson Jesudasan CA, Thomas PA (2013) Spectrum of bacterial keratitis at a tertiary eye care centre in India. Biomed Res Int 2013 (1):181564","DOI":"10.1155\/2013\/181564"},{"issue":"2","key":"5484_CR182","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/112067211002000207","volume":"20","author":"B Chawla","year":"2010","unstructured":"Chawla B, Agarwal P, Tandon R, Titiyal JS, Sharma N, Agarwal T, Navak N, Satpathy G (2010) In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones. Eur J Ophthalmol 20(2):300\u2013305","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"5484_CR183","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00417-023-06362-0","volume":"262","author":"AA Nayel","year":"2024","unstructured":"Nayel AA, Hamdy NA, Massoud TH, Mohamed NM (2024) A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt. Graefes Arch Clin Exp Ophthalmol 262(6):1865\u20131882","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"5484_CR184","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.22207\/JPAM.16.3.12","volume":"16","author":"M Al-Kaffas","year":"2022","unstructured":"Al-Kaffas M, Haggag MG, Soliman SM, Ghalwash AA, Alkaffas M (2022) Genetic Identification of Virulence Genes Associated with Keratitis in Egyptian Population. J Pure Appl Microbiol 16(3):1714\u20131721","journal-title":"J Pure Appl Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05484-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05484-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05484-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:35:30Z","timestamp":1783013730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05484-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":184,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5484"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05484-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}